Immunoprecise Antibodies Ltd
XTSX:IPA
Immunoprecise Antibodies Ltd
XTSX:IPA
Price:
6.5 CAD
0.78%
Market Closed
Updated:
May 10, 2024
Immunoprecise Antibodies Ltd
Pre-Tax Income
|
Immunoprecise Antibodies Ltd
Pre-Tax Income Peer Comparison
Comparables:
ABCL
ARCH
RP
IOT
Competitive Pre-Tax Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Pre-Tax Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Immunoprecise Antibodies Ltd
XTSX:IPA
|
Pre-Tax Income
-CA$6m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Abcellera Biologics Inc
NASDAQ:ABCL
|
Pre-Tax Income
-$174m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Arch Biopartners Inc
XTSX:ARCH
|
Pre-Tax Income
-CA$5.5m
|
CAGR 3-Years
14%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-39%
|
|
|
Replicel Life Sciences Inc
XTSX:RP
|
Pre-Tax Income
-CA$69.3k
|
CAGR 3-Years
69%
|
CAGR 5-Years
51%
|
CAGR 10-Years
N/A
|
|
|
Innovotech Inc
XTSX:IOT
|
Pre-Tax Income
-CA$157.6k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-4%
|
CAGR 10-Years
15%
|
See Also
What is Immunoprecise Antibodies Ltd's Pre-Tax Income?
Pre-Tax Income
-6m
CAD
-6m
CAD
Based on the financial report for Apr 30, 2021, Immunoprecise Antibodies Ltd's Pre-Tax Income amounts to -6m CAD.
What is Immunoprecise Antibodies Ltd's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 3Y
-6%
-6%
Over the last year, the Pre-Tax Income growth was -13%. The average annual Pre-Tax Income growth rates for Immunoprecise Antibodies Ltd have been -6% over the past three years .
You don't have any saved screeners yet
